— OPINION —
Last week, the U.S. Food and Drug Administration published the results of its internal review of the agency’s actions — and inaction — in connection with the February 2022
Patient counts in several ongoing outbreaks of foodborne illnesses continue to increase, according to the Food and Drug Administration.
The agency is currently investigating 10 outbreaks. The investigations are at
By Robert Califf, FDA Commissioner
For the past several months, the U.S. Food and Drug Administration has been working around the clock with our U.S. government partners, including
A new outbreak of infections from Listeria monocytogenes has been reported by the FDA, bringing the agency’s number of open investigations to 10.
The Food and Drug Administration reports
Abbott Nutrition is recalling certain Similac bottles of formula over a packaging defect.
Early this year, Abbott initiated a large recall of some of its infant formula products and closed
The FDA has closed investigations on two outbreaks and is continuing to investigate another eight.
An investigation into an outbreak of “adverse events” involving 558 patients who ate Lucky Charms
The FDA has 11 open outbreak investigations with a total of more than 1,350 people sickened. A new outbreak of Salmonella Mississippi accounts for 99 of those patients.
The
Federal officials report that the number of patients in an outbreak of infections from the Cyclospora parasite have increased by more than a dozen in the past week.
The Food
Federal officials are investigating a new outbreak of infections from the Cyclospora parasite, but little information is available.
The Food and Drug Administration reports that it has begun traceback efforts
The FDA is investigating a new outbreak of dozens of infections caused by the Cyclospora parasite.
Little information has been released, but the Food and Drug Administration is reporting that
UPDATED — This version of this story includes quotes from Commissioner Robert Califf and U.S. Rep. Rosa Delauro.
A shakeup of the chain of command at the FDA may be
It is unclear what actions an infant formula manufacturer is taking to clean its production facility after it was inundated recently with floodwaters.
Abbott Nutrition shut down operations at its
